190 related articles for article (PubMed ID: 30544937)
21. Epiphyseal growth plate and secondary peripheral chondrosarcoma: the neighbours matter.
de Andrea CE; Hogendoorn PC
J Pathol; 2012 Jan; 226(2):219-28. PubMed ID: 21956842
[TBL] [Abstract][Full Text] [Related]
22. Improved differentiation of benign osteochondromas from secondary chondrosarcomas with standardized measurement of cartilage cap at CT and MR imaging.
Bernard SA; Murphey MD; Flemming DJ; Kransdorf MJ
Radiology; 2010 Jun; 255(3):857-65. PubMed ID: 20392983
[TBL] [Abstract][Full Text] [Related]
23. Ext-mutation analysis in Italian sporadic and hereditary osteochondromas.
Gigante M; Matera MG; Seripa D; Izzo AM; Venanzi R; Giannotti A; Digilio MC; Gravina C; Lazzari M; Monteleone G; Monteleone M; Dallapiccola B; Fazio VM
Int J Cancer; 2001 Nov; 95(6):378-83. PubMed ID: 11668521
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier.
Khalil R; Boels MGS; ; van den Berg BM; Bruijn JA; Rabelink TJ; Hogendoorn PCW; Baelde HJ
Mol Genet Genomics; 2022 Mar; 297(2):397-405. PubMed ID: 35103870
[TBL] [Abstract][Full Text] [Related]
25. Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in Hereditary Multiple Exostoses.
Huegel J; Mundy C; Sgariglia F; Nygren P; Billings PC; Yamaguchi Y; Koyama E; Pacifici M
Dev Biol; 2013 May; 377(1):100-12. PubMed ID: 23458899
[TBL] [Abstract][Full Text] [Related]
26. Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation.
Busse M; Feta A; Presto J; Wilén M; Grønning M; Kjellén L; Kusche-Gullberg M
J Biol Chem; 2007 Nov; 282(45):32802-10. PubMed ID: 17761672
[TBL] [Abstract][Full Text] [Related]
27. Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.
Cheung PK; McCormick C; Crawford BE; Esko JD; Tufaro F; Duncan G
Am J Hum Genet; 2001 Jul; 69(1):55-66. PubMed ID: 11391482
[TBL] [Abstract][Full Text] [Related]
28. Biosynthesis of heparan sulfate in EXT1-deficient cells.
Okada M; Nadanaka S; Shoji N; Tamura J; Kitagawa H
Biochem J; 2010 May; 428(3):463-71. PubMed ID: 20377530
[TBL] [Abstract][Full Text] [Related]
29. Osteochondromas: review of the clinical, radiological and pathological features.
Kitsoulis P; Galani V; Stefanaki K; Paraskevas G; Karatzias G; Agnantis NJ; Bai M
In Vivo; 2008; 22(5):633-46. PubMed ID: 18853760
[TBL] [Abstract][Full Text] [Related]
30. Chondrocytes respond to an altered heparan sulfate composition with distinct changes of heparan sulfate structure and increased levels of chondroitin sulfate.
Bachvarova V; Dierker T; Esko J; Hoffmann D; Kjellen L; Vortkamp A
Matrix Biol; 2020 Nov; 93():43-59. PubMed ID: 32201365
[TBL] [Abstract][Full Text] [Related]
31. Heparin-like heparan sulfate from rabbit cartilage.
Parra A; Veraldi N; Locatelli M; Fini M; Martini L; Torri G; Sangiorgi L; Bisio A
Glycobiology; 2012 Feb; 22(2):248-57. PubMed ID: 21933839
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle deregulation and mosaic loss of Ext1 drive peripheral chondrosarcomagenesis in the mouse and reveal an intrinsic cilia deficiency.
de Andrea CE; Zhu JF; Jin H; Bovée JV; Jones KB
J Pathol; 2015 Jun; 236(2):210-8. PubMed ID: 25644707
[TBL] [Abstract][Full Text] [Related]
33. The neoplastic pathogenesis of solitary and multiple osteochondromas.
Porter DE; Simpson AH
J Pathol; 1999 Jun; 188(2):119-25. PubMed ID: 10398153
[TBL] [Abstract][Full Text] [Related]
34. Familial solitary chondrosarcoma resulting from germline EXT2 mutation.
Heddar A; Fermey P; Coutant S; Angot E; Sabourin JC; Michelin P; Parodi N; Charbonnier F; Vezain M; Bougeard G; Baert-Desurmont S; Frébourg T; Tournier I
Genes Chromosomes Cancer; 2017 Feb; 56(2):128-134. PubMed ID: 27636706
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures.
Zuntini M; Salvatore M; Pedrini E; Parra A; Sgariglia F; Magrelli A; Taruscio D; Sangiorgi L
Clin Genet; 2010 Dec; 78(6):507-16. PubMed ID: 20662852
[TBL] [Abstract][Full Text] [Related]
36. Is total-body MRI useful as a screening tool to rule out malignant progression in patients with multiple osteochondromas? Results in a single-center cohort of 319 adult patients.
Van der Woude HJ; Flipsen M; Welsink C; Van der Zwan AL; Ham SJ
Skeletal Radiol; 2024 Jan; 53(1):141-150. PubMed ID: 37338590
[TBL] [Abstract][Full Text] [Related]
37. Dysplasia epiphysealis hemimelica (Trevor disease): a rare developmental disorder of bone mimicking osteochondroma of long bones.
Glick R; Khaldi L; Ptaszynski K; Steiner GC
Hum Pathol; 2007 Aug; 38(8):1265-72. PubMed ID: 17490719
[TBL] [Abstract][Full Text] [Related]
38. [Osteochondroma and multiple osteochondromas: recommendations on the diagnostics and follow-up with special consideration to the occurrence of secondary chondrosarcoma].
Herget GW; Kontny U; Saueressig U; Baumhoer D; Hauschild O; Elger T; Südkamp NP; Uhl M
Radiologe; 2013 Dec; 53(12):1125-36. PubMed ID: 24129968
[TBL] [Abstract][Full Text] [Related]
39. Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.
de Andrea CE; San-Julian M; Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
[TBL] [Abstract][Full Text] [Related]
40. Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma.
Tsuchiya T; Osanai T; Ogose A; Tamura G; Chano T; Kaneko Y; Ishikawa A; Orui H; Wada T; Ikeda T; Namba M; Takigawa M; Kawashima H; Hotta T; Tsuchiya A; Ogino T; Motoyama T
Cancer Genet Cytogenet; 2005 Apr; 158(2):148-55. PubMed ID: 15796962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
